Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma

Overview of attention for article published in Leukemia, February 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 7,433 followers.

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.